Patiënten en de farmaceutische industrie: 'direct-to-consumer-advertising'

dr D. Bijl
Nr 11|2008 (42)|Pagina 106-108|Nieuw|01-11-2008

  1. Sykes R. The influence of the Pharmaceutical Industry. House of Commons, Health Committee. Fourth report of session 2004-5, volume 1, p. 101. 
  2. Furberg CD, et al. The FDA and drug safety: a proposal for sweeping changes. Arch Intern Med 2006; 166: 1938-1942.
  3. Donohie JM, et al. A decade of direct-to-consumer advertising of prescription drugs. N Engl J Med 2007; 357: 673-681.
  4. Law MR, et al. Effect of illicit direct to consumer advertising on use of etanercept, mometasone, and tegaserod in Canada: controlled longitudinal study. BMJ 2008; 337: a1055.
  5. Mintzes B. Direct to consumer advertising of prescription drugs. [editorials] BMJ 2008; 337: a985.
  6. http://66.71.191.169/isdbweb/pag/documents/2_001.pdf.
  7. http://66.71.191.169/isdbweb/pag/documents/1.pdf.

Auteurs

  • dr D. Bijl